Velindre University NHS Trust

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Gastric and oesophageal cancer1 trial
• Melanoma1 trial
• Metastatic breast cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Not yet recruiting1 trial
• Terminated1 trial

Lead sponsor

• ETOP IBCSG Partners Foundation1 trial
• NuCana plc1 trial
• Relay Therapeutics, Inc.1 trial
• Scancell Ltd1 trial
• Taiho Oncology, Inc.1 trial
• and 2 more

Running trials

• Recruiting

  A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

  NCT07128199· Phase 3· Taiho Oncology, Inc.· Source

  Contact: Taiho Oncology, Inc.

• Recruiting

  Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  NCT06982521· Phase 3· Relay Therapeutics, Inc.· Source

  Contact: Relay Therapeutics, Inc

• Recruiting

  A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

  NCT06284317· Phase 3· ETOP IBCSG Partners Foundation· Source

  Contact: Paul Shaw

• Recruiting

  Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

  NCT06440174· University Hospital Southampton NHS Foundation Trust· Source

  Contact: Emma John

• Active, not recruiting

  Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer

  NCT04067713· University College, London· Source

• Active, not recruiting

  SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

  NCT04079166· Phase 2· Scancell Ltd· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting
• Childhood cancers1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Metastatic breast cancer1 recruiting

Closed trials

• Terminated

  A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

  NCT05678257· Phase 2· NuCana plc· Source